PI Industries Ltd. - Research Center
523642 PIIND Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 3,797.90 | 3,193.10 | 2,652.10 | 2,358.40 | 2,039.00 |
| Operating profit | 1,028.60 | 767.40 | 588.90 | 530.90 | 484.70 |
| Interest | 3.30 | 24.40 | 5.70 | 6.50 | 17.40 |
| Gross profit | 1,128.50 | 801.20 | 628.70 | 577.60 | 502.70 |
| EPS (Rs) | 56.57 | 38.11 | 27.59 | 27.24 | 22.44 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 103.20 | 58.20 | 45.50 | 53.20 | 35.40 |
| Stock adjustment | 108.00 | -121.20 | 81.70 | -241.90 | -47.40 |
| Raw material | 1,790.30 | 1,788.60 | 1,312.70 | 1,430.80 | 1,046.70 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 284.80 | 240.90 | 222.30 | 210.60 | 179.20 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 586.20 | 517.40 | 446.50 | 428.00 | 375.80 |
| Provisions made | - | - | - | - | - |
| Depreciation | 122.10 | 110.00 | 101.70 | 88.50 | 80.00 |
| Taxation | 146.60 | 111.90 | 107.60 | 75.10 | 81.60 |
| Net profit / loss | 859.80 | 579.30 | 419.40 | 414.00 | 341.10 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.20 | 15.20 | 15.20 | 15.20 | 15.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 27.08 | 24.03 | 22.21 | 22.51 | 23.77 |
| GPM (%) | 28.93 | 24.64 | 23.31 | 23.95 | 24.23 |
| NPM (%) | 22.04 | 17.82 | 15.55 | 17.17 | 16.44 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis